The Company provides testing services for the detection of abused substances through the analysis of hair samples by utilizing a patented technology to perform radioimmunoassays on enzymatically dissolved hair samples.


Updates from The Motley Fool

Latest updates on Psychemedics from Fool.com.

There is no available coverage of Psychemedics at this time.



Stock Performance

View Interactive PMD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Psychemedics.
Current Price: $20.39
Prev Close: $20.60
Open: $20.65
Bid: $19.10
Ask: $25.50
Day's Range: $19.85 - $20.74
52wk Range: $13.00 - $27.46
Volume: 30,383
Avg Vol 22,732
Market Cap: $111M
P/E (ttm): 13.59
EPS (ttm): $1.50
Div & Yield: $0.60 (2.9%)

Company Rating

What our community thinks about Psychemedics.
CAPS Rating 5 out of 5
 
53 Outperform
1 Underperform
CAPS All Stars
 
15 Outperform
0 Underperform

How do you think Psychemedics will perform against the market?



You pick for Psychemedics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Raymond C. Kubacki Jr., CEO

57% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Psychemedics.

The Company provides testing services for the detection of abused substances through the analysis of hair samples by utilizing a patented technology to perform radioimmunoassays on enzymatically dissolved hair samples.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT